BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15966703)

  • 21. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue.
    Eshghyar N; Mohammadi N; Rahrotaban S; Motahhary P; Vahedi Vaez SM
    Arch Iran Med; 2011 Jul; 14(4):276-80. PubMed ID: 21726105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
    Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
    Thariat J; Ahamad A; El-Naggar AK; Williams MD; Holsinger FC; Glisson BS; Allen PK; Morrison WH; Weber RS; Ang KK; Garden AS
    Cancer; 2008 Jun; 112(12):2698-709. PubMed ID: 18429002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoglin as a marker in cervical paragangliomas.
    Eleno N; Düwel A; Muñoz A; Paz-Bouza J; López-Novoa JM; Lozano F
    Head Neck; 2010 Jun; 32(6):737-43. PubMed ID: 19827102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression.
    Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A
    Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
    Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
    Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases.
    Winters R; Naud S; Evans MF; Trotman W; Kasznica P; Elhosseiny A
    Head Neck Pathol; 2008 Dec; 2(4):265-71. PubMed ID: 20614292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator.
    Lam KY; Law S; Luk JM; Wong J
    J Pathol; 2001 Nov; 195(4):435-42. PubMed ID: 11745675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study.
    Marioni G; Staffieri A; Fasanaro E; Stramare R; Giacomelli L; Bernardi E; Val M; Stellini E; de Filippis C; Blandamura S
    J Oral Pathol Med; 2013 Sep; 42(8):606-11. PubMed ID: 23432607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastasis-associated protein 1 expression in oral squamous cell carcinomas: correlation with metastasis and angiogenesis.
    Andishehtadbir A; Najvani AD; Pardis S; Ashkavandi ZJ; Ashraf MJ; Khademi B; Kamali F
    Turk Patoloji Derg; 2015; 31(1):9-15. PubMed ID: 25301048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
    Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
    Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between CD105 and angiogenesis and biological behaviors in squamous carcinoma of larynx].
    Gu X; Xu Y; Wu H; Xu X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(3):125-8. PubMed ID: 16646406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?
    Schimming R; Reusch P; Kuschnierz J; Schmelzeisen R
    J Craniomaxillofac Surg; 2004 Jun; 32(3):176-81. PubMed ID: 15113577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.
    Fonsatti E; Sigalotti L; Arslan P; Altomonte M; Maio M
    Curr Cancer Drug Targets; 2003 Dec; 3(6):427-32. PubMed ID: 14683500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.